EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.

Source:http://linkedlifedata.com/resource/pubmed/id/18455252

Download in:

View as

General Info

PMID
18455252